Description
This procedure involves the administration of a radiopharmaceutical tracer, allowing for the detection of cancerous cells through emitted photons. The combination of PET and CT imaging provides detailed three-dimensional images, enhancing the accuracy of tumor size and location assessment across the entire body.
After meeting the annual Medicare deductible ($1676 per benefit period up to 60 days for inpatient stays under Part A and $257 for outpatient care under Part B in 2026), Medicare patients are typically responsible for 20% of the Medicare-approved amount as coinsurance. The amounts shown are estimates and may vary based on the patient's specific coverage and whether they have supplemental insurance.
$1,458.59
Calculation:
$291.72
Calculation breakdown:
$783.26
Calculation:
$156.65
Standard copayment (20%):$156.65
No crosswalks found.
No alternates found.
No codes found here.
We make no claims to ownership of the coding systems referenced on this platform. Codes and descriptions are produced from claims and chargemaster data available through the CMS-9915-F Transparency in Coverage Final Rule and via state or federal datasets. This service is provided solely as a reference to encourage use of these codes in our chargemaster review and automated billing tools, so that healthcare professionals can understand and correctly report these codes in their claims.